Similar articles

• Bifurcation stenting with drug eluting stents: illustration of the crush technique.

  Sianos G, Vaina S, Hoye A, Serruys PW. Sianos G, et al. Catheter Cardiovasc Interv. 2006 Jun;67(6):839-45. doi: 10.1002/ccd.20742. Catheter Cardiovasc Interv. 2006. PMID: 16649229
• Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.

  Quizhpe AR, Feres F, de Ribamar Costa J Jr, Abizaid A, Maldonado G, Costa R, Abizaid A, Cano M, Moreira AC, Staico R, Mattos LA, Tanajura LF, Chaves A, Centemero M, Sousa AM, Sousa JE. Quizhpe AR, et al. Am Heart J. 2007 Aug;154(2):373-8. doi: 10.1016/j.ahj.2007.04.027. Am Heart J. 2007. PMID: 17643591
• Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.

  Noordeloos AM, Soullié T, Duckers HJ, Serruys PW. Noordeloos AM, et al. Endothelium. 2006 Nov-Dec;13(6):431-9. doi: 10.1080/10623320601066812. Endothelium. 2006. PMID: 17169775 Review.
• Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.

  Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Marzocchi A, et al. Circulation. 2007 Jun 26;115(25):3181-8. doi: 10.1161/CIRCULATIONAHA.106.667592. Epub 2007 Jun 11. Circulation. 2007. PMID: 17562952
• The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.

  Ray GM, Nawarskas JJ, Frishman WH. Ray GM, et al. Cardiol Rev. 2006 May-Jun;14(3):143-50. doi: 10.1097/01.crd.0000214683.72810.87. Cardiol Rev. 2006. PMID: 16628023 Review.